Virtu Financial’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Virtu Financial's GPCR Position: Q3 2026 in Review
Virtu Financial opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 11,314 shares worth $354K. The stake represents 0.01% of the portfolio and ranks #686 among its holdings. This is a return to the name: Virtu Financial previously reported a position in GPCR as recently as Q2 2025.
Virtu Financial first reported a position in GPCR in Q1 2024 and has held it in 4 quarters since. The position peaked at $394K in Q2 2024. 170 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Virtu Financial held 11,314 shares of Structure Therapeutics worth $354K as of Q3 2026.
- Structure Therapeutics was a new Virtu Financial position in Q3 2026.
- Structure Therapeutics made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #686 holding.
- Virtu Financial first reported a position in Structure Therapeutics in Q1 2024 and has held it in 4 quarters since.
- Virtu Financial's Structure Therapeutics position peaked at $394K in Q2 2024.
- 170 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.